Cargando…
How has mass drug administration with dihydroartemisinin-piperaquine impacted molecular markers of drug resistance? A systematic review
The World Health Organization (WHO) recommends surveillance of molecular markers of resistance to anti-malarial drugs. This is particularly important in the case of mass drug administration (MDA), which is endorsed by the WHO in some settings to combat malaria. Dihydroartemisinin-piperaquine (DHA-PP...
Autores principales: | Moss, Sophie, Mańko, Emilia, Krishna, Sanjeev, Campino, Susana, Clark, Taane G., Last, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188255/ https://www.ncbi.nlm.nih.gov/pubmed/35690758 http://dx.doi.org/10.1186/s12936-022-04181-y |
Ejemplares similares
-
Adherence to Mass Drug Administration with Dihydroartemisinin–Piperaquine and Plasmodium falciparum Clearance in Southern Province, Zambia
por: Finn, Timothy P., et al.
Publicado: (2020) -
Impact of Four Rounds of Mass Drug Administration with Dihydroartemisinin–Piperaquine Implemented in Southern Province, Zambia
por: Eisele, Thomas P., et al.
Publicado: (2020) -
Treatment Coverage Estimation for Mass Drug Administration for Malaria with Dihydroartemisinin–Piperaquine in Southern Province, Zambia
por: Finn, Timothy P., et al.
Publicado: (2020) -
Molecular markers of dihydroartemisinin-piperaquine resistance in northwestern Thailand
por: Win, Khine Nwe, et al.
Publicado: (2022) -
Mass Drug Administration With Dihydroartemisinin-piperaquine and Malaria Transmission Dynamics in The Gambia: A Prospective Cohort Study
por: Mwesigwa, Julia, et al.
Publicado: (2019)